Skip to main content

SARC 024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcomas - Cohort A

Research Grant
Duke Scholars

Awarded By

Sarcoma Alliance for Research Through Collaboration

Start Date

September 1, 2015

End Date

August 31, 2018
 

Awarded By

Sarcoma Alliance for Research Through Collaboration

Start Date

September 1, 2015

End Date

August 31, 2018